2) letrozole (LE)
来曲唑(LE)
1.
Objective: To explore the clinical results and the cost-effectiveness of using the aromatase inhibitor, letrozole (LE), in conjunction with FSH for controlled ovarian stimulation in patients with PCOS undergoing IVF-ET.
目的:探讨来曲唑(LE)联合FSH在多囊卵巢综合征(PCOS)患者IVF-ET或ICSI中的应用及效价分析。
3) Lelrozol
来曲唑片, 芙瑞
4) aromatase inhibitor letrozole
芳香化酶抑制剂来曲唑
1.
Objective To observe effects of marvelon(desogestrel and ethinyl estradiol)and aromatase inhibitor letrozole sequential therapy on endocrine functions and fertility of women with polycystic ovary syndrome(PCOS).
目的探讨妈富隆(地索高诺酮+乙炔雌二醇)与芳香化酶抑制剂来曲唑序贯用药对多囊卵巢综合征患者内分泌及生殖功能的影响。
5) zoledronic acid
唑来膦酸
1.
Study on the novel process for preparation of zoledronic acid;
异环型双膦酸类药物唑来膦酸合成新工艺研究
2.
An observation on curative effect of zoledronic acid on metastatic bone pain;
唑来膦酸治疗骨转移癌的临床疗效
3.
Clinical study of metastatic bone tumour treated with radiotherapy and radiotherapy combined zoledronic acid;
单纯放疗与放疗联合唑来膦酸治疗骨转移瘤临床观察
6) Zoledronic acid
唑来磷酸
1.
Objective:To evaluate and study therapeutic effects of androgen deprivation in combination with zoledronic acid on pain relief as well as improvement of quality of life among patients with bone metastases from prostate cancer.
目的:评价内分泌治疗联合唑来磷酸对缓解前列腺癌患者骨转移性疼痛和改善患者生活质量疗效。
2.
[Conclusion]Zoledronic acid combined with chemotherapy in treatment of bone metastasis of lung cancer is effective and safe.
目的观察唑来磷酸联合化疗对肺癌骨转移的止痛效果和不良反应。
补充资料：来曲唑
分子式：C17H11N5
分子量：285.10
CAS号：112809-51-5
性质：该品为白色或类白色结晶性粉末。
制备方法：暂无
用途：暂无
分子量：285.10
CAS号：112809-51-5
性质：该品为白色或类白色结晶性粉末。
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条